Odum N - Search Results

1

The role of cytokine signaling in the pathogenesis of cutaneous T-cell lymphoma.

Abraham RM, Zhang Q, Odum N, Wasik MA. Abraham RM, et al. Among authors: odum n. Cancer Biol Ther. 2011 Dec 15;12(12):1019-22. doi: 10.4161/cbt.12.12.18144. Epub 2011 Dec 15. Cancer Biol Ther. 2011. PMID: 22236880 Free PMC article. Review.

2

Lack of phosphotyrosine phosphatase SHP-1 expression in malignant T-cell lymphoma cells results from methylation of the SHP-1 promoter.

Zhang Q, Raghunath PN, Vonderheid E, Odum N, Wasik MA. Zhang Q, et al. Among authors: odum n. Am J Pathol. 2000 Oct;157(4):1137-46. doi: 10.1016/S0002-9440(10)64629-9. Am J Pathol. 2000. PMID: 11021818 Free PMC article.

3

STAT3-mediated constitutive expression of SOCS-3 in cutaneous T-cell lymphoma.

Brender C, Nielsen M, Kaltoft K, Mikkelsen G, Zhang Q, Wasik M, Billestrup N, Odum N. Brender C, et al. Among authors: odum n. Blood. 2001 Feb 15;97(4):1056-62. doi: 10.1182/blood.v97.4.1056. Blood. 2001. PMID: 11159537 Free article.

4

Constitutive STAT3-activation in Sezary syndrome: tyrphostin AG490 inhibits STAT3-activation, interleukin-2 receptor expression and growth of leukemic Sezary cells.

Eriksen KW, Kaltoft K, Mikkelsen G, Nielsen M, Zhang Q, Geisler C, Nissen MH, Röpke C, Wasik MA, Odum N. Eriksen KW, et al. Among authors: odum n. Leukemia. 2001 May;15(5):787-93. doi: 10.1038/sj.leu.2402093. Leukemia. 2001. PMID: 11368440

5

Multilevel dysregulation of STAT3 activation in anaplastic lymphoma kinase-positive T/null-cell lymphoma.

Zhang Q, Raghunath PN, Xue L, Majewski M, Carpentieri DF, Odum N, Morris S, Skorski T, Wasik MA. Zhang Q, et al. Among authors: odum n. J Immunol. 2002 Jan 1;168(1):466-74. doi: 10.4049/jimmunol.168.1.466. J Immunol. 2002. PMID: 11751994

6

SHP2 regulates IL-2 induced MAPK activation, but not Stat3 or Stat5 tyrosine phosphorylation, in cutaneous T cell lymphoma cells.

Lundin Brockdorff J, Woetmann A, Mustelin T, Kaltoft K, Zhang Q, Wasik MA, Röpke C, Ødum N. Lundin Brockdorff J, et al. Among authors: odum n. Cytokine. 2002 Nov 24;20(4):141-7. doi: 10.1006/cyto.2002.1986. Cytokine. 2002. PMID: 12543077

7

In vivo activation of STAT3 in cutaneous T-cell lymphoma. Evidence for an antiapoptotic function of STAT3.

Sommer VH, Clemmensen OJ, Nielsen O, Wasik M, Lovato P, Brender C, Eriksen KW, Woetmann A, Kaestel CG, Nissen MH, Ropke C, Skov S, Ødum N. Sommer VH, et al. Among authors: odum n. Leukemia. 2004 Jul;18(7):1288-95. doi: 10.1038/sj.leu.2403385. Leukemia. 2004. PMID: 15141228

8

Constitutive SOCS-3 expression protects T-cell lymphoma against growth inhibition by IFNalpha.

Brender C, Lovato P, Sommer VH, Woetmann A, Mathiesen AM, Geisler C, Wasik M, Ødum N. Brender C, et al. Among authors: odum n. Leukemia. 2005 Feb;19(2):209-13. doi: 10.1038/sj.leu.2403610. Leukemia. 2005. PMID: 15618960

9

Inhibition of ALK enzymatic activity in T-cell lymphoma cells induces apoptosis and suppresses proliferation and STAT3 phosphorylation independently of Jak3.

Marzec M, Kasprzycka M, Ptasznik A, Wlodarski P, Zhang Q, Odum N, Wasik MA. Marzec M, et al. Among authors: odum n. Lab Invest. 2005 Dec;85(12):1544-54. doi: 10.1038/labinvest.3700348. Lab Invest. 2005. PMID: 16170336 Free article.

10

Multi-gene epigenetic silencing of tumor suppressor genes in T-cell lymphoma cells; delayed expression of the p16 protein upon reversal of the silencing.

Nagasawa T, Zhang Q, Raghunath PN, Wong HY, El-Salem M, Szallasi A, Marzec M, Gimotty P, Rook AH, Vonderheid EC, Odum N, Wasik MA. Nagasawa T, et al. Among authors: odum n. Leuk Res. 2006 Mar;30(3):303-12. doi: 10.1016/j.leukres.2005.08.012. Epub 2005 Sep 26. Leuk Res. 2006. PMID: 16185764

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

349 results

Search Page

Filters